Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2023-12-14 00:00:00 ET · period of report 2023-12-13 · accession 0001048477-23-000059 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-14 | 2023-12-13 | BMRN | Davis George Eric | EVP, CLO | S - Sale | $95.30 | -13.8K | 55.7K | -20% | -$1.31M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-13 | S | D | 13,764 | $95.30 | 55,710 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on September 13, 2023. |